QUOIN PHARMACEUTICALS, LTD. (QNRX)
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
KULR ONE Battery Architecture Enters Electric Aviation: KULR Technology Group Signs Agreement with Robinson Helicopter as Battery Co-Developer for eR66 Electric Helicopter Demonstrator
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Sol Rashidi, World’s First Chief AI Officer, Joins Agenda at FICO World 2026
Duos Technologies Group Sets Fourth Quarter and Full Year 2025 Earnings Call for Tuesday, March 31, 2026 at 4:30 PM ET
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report
StubHub Opens Direct Path from Primary Ticketing to 125 Million Fans, Expanding with vivenu
Amprius Recognized by TIME as One of America’s Top GreenTech Companies for 2026
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisiniclines Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment